Skip to content

Sex Differences in Postoperative Sleep Quality and Inflammation

Sex Differences in Postoperative Sleep Quality and Inflammation in Patients Undergoing Video-Assisted Thoracoscopic Surgery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04608435
Enrollment
213
Registered
2020-10-29
Start date
2020-10-31
Completion date
2022-02-27
Last updated
2022-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammation Function, Postoperative Pain, Postoperative Sleep Quality, Sex Differences

Keywords

sex differences, postoperative sleep quality, postoperative pain, inflammation function

Brief summary

Video-Assisted Thoracoscopic Surgery(VATS) is among the most common and disabling persistent pain and inflammation conditions, with increasing prevalence in the developed world, and affects women to a greater degree than men. And sleep disruption also remains a challenging problem in surgical settings. Postoperative sleep disturbances (POSD) are defined as changes in the sleep structure and quality of patients during the early stages after surgery, which are manifested as significantly shortened rapid eye movement (REM) sleep, prolonged awake time, and sleep fragmentation. Long-term POSD may increase the risk of postoperative delirium or cognitive dysfunction and delay recovery, thereby worsening the patient's physical condition. The aim of the study was to investigate the effect of sex differences on postoperative pain, inflammation and sleep quality among patients who have undergone video-assisted thoracoscopic surgery under general anesthesia.

Interventions

OTHERVideo-Assisted Thoracoscopic Surgery

patients receive Video-Assisted Thoracoscopic Surgery under general anesthesia

Sponsors

Shengjing Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* 18-80 years old * ASA I-III * under general anesthesia

Exclusion criteria

* patients with central nervous system and mental diseases; * patients with preoperative sleep disturbances; * patients with a history of sedative, analgesic, or antidepression drug use; * patients with sleep apnea or moderate and severe obstructive sleep apnea-hypopnea syndrome;

Design outcomes

Primary

MeasureTime frameDescription
sleep quality of one night before surgeryfirst night before surgeryUse Athens insomnia scale to test the sleep quality the first night before surgery
sleep quality of first night after surgeryfirst night after surgeryUse Athens insomnia scale to test the sleep quality the first night after surgery
sleep quality of third night after surgerythird night after surgeryUse Athens insomnia scale to test the sleep quality the third night after surgery

Secondary

MeasureTime frameDescription
visual analog scale(VAS) score after surgeryone day before surgeryevaluate VAS score after surgery
Postoperative cognition evaluationone day before surgeryUse MMSE Mini-Mental State Examination (MMSE) was also evaluated at Sleep preop 1, Sleep POD 1 and Sleep POD 3.18 Each correct answer is 1 point, and error or unknown is 0 point. The unsuitable one is 9 points, and refusing to answer or incomprehension is 8 points. In the total score, 8 points and 9 points are calculated by 0 points. The highest score is 30 points. The division of dementia or not is related to the degree of education. The dementia is affirmed by the patient who is illiterate and less than 17 points, the primary school is less than 20 points, and more than middle school is less than 24 points. The scores which from 27 to 30 is normal, 21 to 26 of mild, 10 to 20 of moderate, and from 0 to 9 is severe.
postoperative adverse effect24 hours after surgeryevaluate postoperative adverse effect 24 hours after surgery
perioperative inflammation functiontwo days before surgeryevaluate neutrophils

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026